FANCB and Alzheimer disease: Although the regulation effect of Mn3O4 nanozymes on microglial phenotype in this study weakened after 8 weeks of treatment, it significantly reduced fAβ pathology in 5×FAD mice and ameliorated learning and memory impairment, providing a new insight for anti-neuroinflammatory treatment of AD.